
Ceva, Inc. Announces Third Quarter 2024 Financial Results
Ceva, Inc. AND ITS SUBSIDIARIES |
||||
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF LOSS – U.S. GAAP |
||||
U.S. dollars in thousands, except per share data |
||||
|
|
|
||
|
Three months ended |
Nine months ended |
||
|
September 30, |
September 30, |
||
|
2024 |
2023 |
2024 |
2023 |
|
Unaudited |
Unaudited |
Unaudited |
Unaudited |
Revenues: |
|
|
|
|
Licensing and related revenues |
$ |
$ |
$ |
$ |
Royalties |
11,633 |
10,133 |
33,450 |
27,518 |
|
|
|
|
|
Total revenues |
27,207 |
24,073 |
77,716 |
73,257 |
|
|
|
|
|
Cost of revenues |
3,961 |
2,357 |
9,397 |
9,389 |
|
|
|
|
|
Gross profit |
23,246 |
21,716 |
68,319 |
63,868 |
|
|
|
|
|
Operating expenses: |
|
|
|
|
Research and development, net |
17,990 |
17,814 |
54,739 |
54,544 |
Sales and marketing |
3,088 |
2,862 |
8,999 |
8,213 |
General and administrative |
4,642 |
3,608 |
11,751 |
11,346 |
Amortization of intangible assets |
150 |
149 |
449 |
445 |
Total operating expenses |
25,870 |
24,433 |
75,938 |
74,548 |
|
|
|
|
|
Operating loss |
(2,624) |
(2,717) |
(7,619) |
(10,680) |
Financial income, net |
2,299 |
924 |
4,962 |
3,497 |
Reevaluation of marketable equity securities |
21 |
160 |
(97) |
(76) |
|
|
|
|
|
Loss before taxes on income |
(304) |
(1,633) |
(2,754) |
(7,259) |
Income tax expense |
1,007 |
1,117 |
4,296 |
3,080 |
Net loss from continuing operation |
(1,311) |
(2,750) |
(7,050) |
(10,339) |
Discontinued operation |
- |
(2,207) |
- |
(5,308) |
|
|
|
|
|
Net loss |
$ |
$ |
$ |
$ |
|
|
|
|
|
Basic and diluted net loss per share: |
|
|
|
|
|
$ |
$ |
$ |
$ |
|
- |
(0.09) |
- |
(0.23) |
Basic and diluted net loss per share |
$ |
$ |
$ |
$ |
|
|
|
|
|
Weighted-average shares used to compute net loss |
|
|
|
|
Basic and diluted |
23,678 |
23,605 |
23,605 |
23,473 |
Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures U.S. Dollars in thousands, except per share amounts |
||||
|
|
|
||
|
Three months ended |
Nine months ended |
||
|
September 30, |
September 30, |
||
|
2024 |
2023 |
2024 |
2023 |
|
Unaudited |
Unaudited |
Unaudited |
Unaudited |
GAAP net loss |
$ |
$ |
$ |
$ |
Equity-based compensation expense included in cost of |
176 |
216 |
570 |
636 |
Equity-based compensation expense included in research |
2,421 |
2,257 |
6,866 |
6,703 |
Equity-based compensation expense included in sales |
491 |
478 |
1,307 |
1,305 |
Equity-based compensation expense included in general |
1,120 |
1,018 |
2,936 |
2,787 |
Amortization of intangible assets related to acquisition |
279 |
278 |
835 |
753 |
Costs associated with business and asset acquisitions |
251 |
100 |
783 |
195 |
(Income) loss associated with the remeasurement of |
(21) |
(160) |
97 |
76 |
Non-GAAP from discontinued operations |
- |
1,184 |
- |
3,233 |
Non-GAAP net income |
$ |
$ |
$ |
$ |
GAAP weighted-average number of Common Stock |
23,678 |
23,605 |
23,605 |
23,473 |
Weighted-average number of shares related to |
1,544 |
1,304 |
1,462 |
1,172 |
Weighted-average number of Common Stock used in |
25,222 |
24,909 |
25,067 |
24,645 |
|
|
|
|
|
|
|
|
|
|
GAAP diluted loss per share |
$ |
$ |
$ |
$ |
Equity-based compensation expense |
$ |
$ |
$ |
$ |
Amortization of intangible assets related to acquisition |
$ |
$ |
$ |
$ |
Costs associated with business and asset acquisitions |
$ |
$ |
$ |
$ |
Income (loss) associated with the remeasurement of |
$ |
$ |
$ |
$ |
Non-GAAP from discontinued operation |
- |
$ |
- |
$ |
Non-GAAP diluted earnings |
$ |
$ |
$ |
$ |
|
Three months ended |
Nine months ended |
||
|
September 30, |
September 30, |
||
|
2024 |
2023 |
2024 |
2023 |
|
Unaudited |
Unaudited |
Unaudited |
Unaudited |
GAAP Operating loss |
$ |
$ |
$ |
$ |
Equity-based compensation expense included in cost of |
176 |
216 |
570 |
636 |
Equity-based compensation expense included in |
2,421 |
2,257 |
6,866 |
6,703 |
Equity-based compensation expense included in sales |
491 |
478 |
1,307 |
1,305 |
Equity-based compensation expense included in |
1,120 |
1,018 |
2,936 |
2,787 |
Amortization of intangible assets related to acquisition |
279 |
278 |
835 |
753 |
Costs associated with business and asset acquisitions |
251 |
100 |
783 |
195 |
Total non-GAAP Operating Income |
$ |
$ |
$ |
$ |
|
Three months ended |
Nine months ended |
||
|
September 30, |
September 30, |
||
|
2024 |
2023 |
2024 |
2023 |
|
Unaudited |
Unaudited |
Unaudited |
Unaudited |
|
|
|
|
|
GAAP Gross Profit |
$ |
$ |
$ |
$ |
GAAP Gross Margin |
85 |
90 |
88 |
87 |
|
|
|
|
|
Equity-based compensation expense included in cost of |
176 |
216 |
570 |
636 |
Amortization of intangible assets related to acquisition |
129 |
129 |
386 |
308 |
Total Non-GAAP Gross profit |
$ |
$ |
$ |
$ |
Non-GAAP Gross Margin |
87 |
92 |
89 |
88 |
|
|
|
|
|
Ceva, Inc. AND ITS SUBSIDIARIES INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS |
|||
(U.S. Dollars in thousands) |
|||
|
|
|
|
|
|
September 30, |
December 31, |
|
|
2024 |
2023 (*) |
|
|
Unaudited |
Unaudited |
ASSETS |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents |
|
$ |
$ |
Marketable securities and short-term bank deposits |
|
144,884 |
143,251 |
Trade receivables, net |
|
15,250 |
8,433 |
Unbilled receivables |
|
23,380 |
21,874 |
Prepaid expenses and other current assets |
|
13,970 |
12,526 |
Total current assets |
|
210,712 |
209,371 |
Long-term assets: |
|
|
|
Severance pay fund |
|
6,851 |
7,070 |
Deferred tax assets, net |
|
1,685 |
1,609 |
Property and equipment, net |
|
6,875 |
6,732 |
Operating lease right-of-use assets |
|
5,625 |
6,978 |
Investment in marketable equity securities |
|
309 |
406 |
Goodwill |
|
58,308 |
58,308 |
Intangible assets, net |
|
2,132 |
2,967 |
Other long-term assets |
|
12,394 |
10,644 |
Total assets |
|
$ |
$ |
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
Current liabilities: |
|
|
|
Trade payables |
|
$ |
$ |
Deferred revenues |
|
3,418 |
3,018 |
Accrued expenses and other payables |
|
19,770 |
20,202 |
Operating lease liabilities |
|
2,571 |
2,513 |
Total current liabilities |
|
27,719 |
26,887 |
Long-term liabilities: |
|
|
|
|
|
7,304 |
7,524 |
Operating lease liabilities |
|
2,627 |
3,943 |
Other accrued liabilities |
|
1,471 |
1,390 |
Total liabilities |
|
39,121 |
39,744 |
Stockholders' equity: |
|
|
|
Common stock |
|
24 |
23 |
Additional paid in-capital |
|
256,685 |
252,100 |
Treasury stock |
|
(2,943) |
(5,620) |
Accumulated other comprehensive loss |
|
(956) |
(2,329) |
Retained earnings |
|
12,960 |
20,167 |
Total stockholders' equity |
|
265,770 |
264,341 |
Total liabilities and stockholders' equity |
|
$ |
$ |
|
(*) Derived from audited financial statements. |
SOURCE Ceva, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Comments
No comment